ArticleMethods in molecular biology (Clifton, N.J.)2026
Analysis of Erythrocyte Membrane Alloantigens.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Red blood cell (RBC) transfusion is a critical medical intervention for managing various diseases marked by anemia. However, this treatment carries the risk of alloimmunization, which can result in hemolysis following an incompatible RBC transfusion. Exposure to RBC alloantigens on fetal RBCs can likewise induce a maternal alloimmune response in the setting of pregnancy. Antibody-mediated immunosuppression (AMIS) is currently the only known method to actively prevent alloimmunization following allogeneic RBC exposure. While the mechanism of AMIS remained enigmatic for many years, recent studies suggest that passively administered antibodies may, in part, prevent de novo alloimmunization by inducing the removal of the target antigen from the RBC surface. Although antibody-mediated antigen removal can be detected indirectly by flow cytometry, western blot analysis of the target antigen provides a more definitive assessment of antigen removal following antibody engagement. We will describe the methods used to isolate RBC membrane proteins and analyze the levels of antigen using western blot techniques by employing the Hen egg lysozyme, Ovalbumin, and Duffy (HOD) model system as an example.
Indexed as
Identifiers
42681449What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.